Global Intravenous Anesthetic Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Intravenous Anesthetic Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Intravenous anesthetics are a varied group of compounds that contain such agents as the barbiturates, benzodiazepines, opioids, ketamine, and alpha-2 adrenoceptor agonists Marshall and Longnecker (1996). The intravenous anesthetics are most commonly used for the induction of anesthesia as they act quickly (20 seconds), and induction by this intravenous route is often preferable to induction with an inhalation agent via a face mask.
Intravenous Anesthetic report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Intravenous Anesthetic market is projected to reach US$ 5842.6 million in 2029, increasing from US$ 4470 million in 2022, with the CAGR of 3.8% during the period of 2024 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Intravenous Anesthetic industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Intravenous Anesthetic key manufacturers include AstraZeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Mylan and Hengrui, etc. AstraZeneca, Fresenius-Kabi, AbbVie are top 3 players and held % sales share in total in 2022.
Intravenous Anesthetic can be divided into Tetrazolium, Ketamine and Other,, etc. Tetrazolium is the mainstream product in the market, accounting for % sales share globally in 2022.
Intravenous Anesthetic is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Intravenous Anesthetic industry development. In 2022, global % sales of Intravenous Anesthetic went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Intravenous Anesthetic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
AstraZeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Mylan
Hengrui
Segment by Type
Tetrazolium
Ketamine
Other
Hospitals
Clinics
Others
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Intravenous Anesthetic market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Intravenous Anesthetic, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Intravenous Anesthetic industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Intravenous Anesthetic in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Intravenous Anesthetic introduction, etc. Intravenous Anesthetic Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Intravenous Anesthetic market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Intravenous Anesthetic report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Intravenous Anesthetic market is projected to reach US$ 5842.6 million in 2029, increasing from US$ 4470 million in 2022, with the CAGR of 3.8% during the period of 2024 to 2029. Demand from Hospitals and Clinics are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Intravenous Anesthetic industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029.
Globally, Intravenous Anesthetic key manufacturers include AstraZeneca, Fresenius-Kabi, AbbVie, Baxter Healthcare, B.Braun, Mylan and Hengrui, etc. AstraZeneca, Fresenius-Kabi, AbbVie are top 3 players and held % sales share in total in 2022.
Intravenous Anesthetic can be divided into Tetrazolium, Ketamine and Other,, etc. Tetrazolium is the mainstream product in the market, accounting for % sales share globally in 2022.
Intravenous Anesthetic is widely used in various fields, such as Hospitals, Clinics and Others,, etc. Hospitals provides greatest supports to the Intravenous Anesthetic industry development. In 2022, global % sales of Intravenous Anesthetic went into Hospitals filed.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Intravenous Anesthetic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
AstraZeneca
Fresenius-Kabi
AbbVie
Baxter Healthcare
B.Braun
Mylan
Hengrui
Segment by Type
Tetrazolium
Ketamine
Other
Segment by Application
Hospitals
Clinics
Others
Segment by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Intravenous Anesthetic market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Intravenous Anesthetic, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Intravenous Anesthetic industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Intravenous Anesthetic in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Intravenous Anesthetic introduction, etc. Intravenous Anesthetic Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports Conclusions of Intravenous Anesthetic market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.